The organisations will focus on the delivery of clinical trials which concentrate on rare cancers

Companies’ precision medicine approach has potential to increase clinical trial success rates

Lemons, limes, and fluKey lemon pie? Lime meringue? I’ve been trying all week to think of recipes where […]

TrichotillomaniaMemantine is an NMDA antagonist credited with small positive effects on cognition, mood, and behaviour in people with […]

“There currently isn’t a consensus on what the menopause is,” says Martha Hickey, professor of obstetrics and gynaecology […]

Two errors occurred in this article by Wen Chen and colleagues (BMJ 2023;381:e068915; doi:10.1136/bmj-2021-068915). In the first sentence of […]

More than half of UK doctors who responded to a survey said they had experienced or witnessed abuse […]

ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein

Poolbeg’s platform will possess the capability to generate vaccines for a wide range of diseases

Updated Date: Wed, 14 Jun 2023 00:00:00 EDT